ORGO CIK: 1661181

Organogenesis Holdings Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
62.0
FY22:
24.9
FY23:
30.9
FY24:
14.2
FY25:
−10.3
Change from FY21 to FY25
millions USD
FY21:
−31.2
FY22:
−33.9
FY23:
−24.4
FY24:
−10.0
FY25:
−14.2
Change from FY21 to FY25
millions USD
FY21:
−1.04
FY22:
−2.20
FY23:
−5.51
FY24:
27.6
FY25:
−17.4
millions USD
FY21:
29.7
FY22:
−11.2
FY23:
1.05
FY24:
31.8
FY25:
−41.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.8
FY22:
−9.04
FY23:
6.55
FY24:
4.18
FY25:
−24.5

All amounts in millions USD Data source:SEC EDGAR